Miki Wakada

发表

Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin.

T. Shiraishi, Tatsushi Yoshida, M. Horinaka, 2007, Oncology reports.

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2005, Cancer research.

Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.

T. Kubo, Tatsushi Yoshida, M. Horinaka, 2006, Carcinogenesis.

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2004, Oncogene.

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2005, Cancer research.

Lysocellin, a metabolite of the novel drug 'alopestatin', induces G1 arrest and prevents cytotoxicity induced by etoposide.

M. Wakada, T. Sakai, T. Nikaido, 2006, International journal of oncology.

Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis.

Tatsushi Yoshida, M. Horinaka, M. Wakada, 2008, Biochemical and biophysical research communications.

Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2005, Oncogene.

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2006, Molecular Cancer Therapeutics.

Aclarubicin enhances tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis through death receptor 5 upregulation

T. Shiraishi, Tatsushi Yoshida, Susumu Nakata, 2012, Cancer science.

Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells

Tatsushi Yoshida, T. Sakai, A. Kishi, 2010, FEBS letters.

Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.

Tatsushi Yoshida, M. Horinaka, M. Wakada, 2008, Cancer research.

Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.

Terukazu Nakamura, Tatsushi Yoshida, M. Horinaka, 2011, International journal of oncology.

Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis

M. Horinaka, M. Wakada, T. Sakai, 2010, Clinical Cancer Research.

Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells

Tatsushi Yoshida, M. Horinaka, M. Wakada, 2008, Environmental health and preventive medicine.